Abstract:OATP1B1 and OATP1B3 are two important drug uptake transporters expressed in human hepatocytes. They mediate the uptake of numerous drugs and other compounds and multiple inhibitors have been identified. However, it has also been suggested that these inhibitors may act as substrates for OATPs. Therefore, we wanted to establish the competitive counterflow assay described by Harper and Wright ( Am J Physiol Renal Physiol 2013; 304:F56–67 ) for OATP1B1 and OATP1B3 with the model substrate estradiol‐17β‐glucuronide (E17βG). This assay should allow to identify compounds that are able to exchange for an OATP substrate such as [ 3 H]‐E17βG that was used to preload OATP expressing CHO cells. CHO cells stably expressing either OATP1B1 or OATP1B3 were used and time dependent uptake of 10nM [ 3 H]‐E17βG was determined on 96‐well plates. Uptake reached a steady‐state plateau at 2 hours and addition of unlabeled E17βG to the extracellular medium at this time triggered time and concentration dependent efflux of [ 3 H]‐E17βG from the preloaded cells, indicating that extracellular E17βG exchanged for intracellular [ 3 H]‐E17βG. This assay was then used to test whether several known OATP substrates would also lead to [ 3 H]‐E17βG efflux, indicating that they are exchanged for the intracellular substrate. After preloading the cells with [ 3 H]‐E17βG, addition of known substrates such as E17βG, estrone‐3‐sulfate, bromosulfophthalein, taurocholate, and rifampicin to the extracellular medium indeed resulted in [ 3 H]‐E17βG efflux, confirming that OATP1B1 and OATP1B3 handle their substrates as exchangers. As negative controls we used glucose, glutamic acid, ouabain and metformin which did not result in [ 3 H]‐E17βG efflux. We then began testing known OATP inhibitors to see whether they would trigger [ 3 H]‐E17βG efflux, and thus would be OATP substrates. Among the tested inhibitors, many resulted in [ 3 H]‐E17βG efflux from both OATP1B1 and OATP1B3 expressing CHO cells, and thus seem to be substrates. These included bromocryptine, cyclosporine A, DIDS, indomethacin, ketoconazole, reserpine, and salinomycin. A few, including berberine, erythromycin, gliquidone, nifedipine, and paranitrosaniline seem to be substrates only for OATP1B1. Thus, because the tested substrates do not need to be radiolabeled and the CCF assay can be performed on 96‐well plates, this is a good screening tool to identify OATP inhibitors that are transported substrates. Support or Funding Information This work was supported by the National Institute of Health Grants R01‐GM077335 and P20‐GM103549‐07.

Transepithelial transport of organic anions across the choroid plexus: possible involvement of organic anion transporter and multidrug resistance-associated protein.

Transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II cell monolayer expressing both human organic anion-transporting polypeptide (OATP2/SLC21A6) and Multidrug resistance-associated protein 2 (MRP2/ABCC2)

Molecular Mechanisms for the Selective Transport of Dichlorofluorescein by Human Organic Anion Transporting Polypeptide 1B1

Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions

Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier

Transport of amphipathic anions by human multidrug resistance protein 3

Using a competitive counterflow assay to identify novel cationic substrates of OATP1B1 and OATP1B3

Functional Expression of Carnitine/Organic Cation Transporter 1 in Murine Choroid Plexus

Transport of Bile Acids, Sulfated Steroids, Estradiol 17- -D-Glucuronide, and Leukotriene C4 by Human Multidrug Resistance Protein 8 (ABCC11)

Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4)

Transepithelial transport mechanisms of 7,8-dihydroxyflavone, a small molecular TrkB receptor agonist, in human intestinal Caco-2 cells.

Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain

Characterization of Organic Anion and Cation Transport in Three Human Renal Proximal Tubular Epithelial Models

Establishing the Competitive Counterflow Assay for OATP1B1 and OATP1B3

Human multidrug resistance protein 2 transports the therapeutic bile salt tauroursodeoxycholate

Transporter Protein Expression of Corneal Epithelium in Rabbit and Porcine: Evaluation of Models for Ocular Drug Transport Study

Live tissue imaging of organic cation and anion transport at the blood‐CSF barrier reveals specific transporter function and distinct transcellular pathways

The Organic Anion-Transporting Peptide 2B1 Is Localized in the Basolateral Membrane of the Human Jejunum and Caco-2 Monolayers

Wide expression of type I Na+-phosphate cotransporter 3 (NPT3/SLC17A2), a membrane potential-driven organic anion transporter

Properties and regulation of organic cation transport in freshly isolated mouse proximal tubules analyzed with a fluorescence reader-based method

PDZK1 and NHERF1 Regulate the Function of Human Organic Anion Transporting Polypeptide 1A2 (OATP1A2) by Modulating Its Subcellular Trafficking and Stability